Richard Aplenc

28PUBLICATIONS
192CO-AUTHORS
Predictive and prognostic markersHaematological tumoursGene and molecular therapyApplications in healthInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 06, 2026
Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Apr 10, 2026
Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups.

Tamara P Miller, Richard Aplenc, Charles Minard

|Sep 19, 2025
AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy.

Alix E Seif, Sara L McDonough, Emily M Becker-Haimes

|May 28, 2025
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Haley Newman, Shawn H R Lee, Petri Pölönen

Pageof 5

Frequent Collaborators

10 joint publications

Alan S Gamis

7 joint publications

Edward Anders Kolb

6 joint publications

David T Teachey

5 joint publications

Mike R Loken